RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

310 hedge funds and large institutions have $3.68B invested in Ultragenyx Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 110 increasing their positions, 108 reducing their positions, and 42 closing their positions.

Holders
310
Holders Change
+12
Holders Change %
+4.03%
% of All Funds
4.13%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
55
Increased
110
Reduced
108
Closed
42
Calls
$31.5M
Puts
$37.9M
Net Calls
-$6.41M
Net Calls Change
-$10.7M

Top Buyers

1
VPC
1
Vestal Point Capital
New York
$63.1M
2
BlackRock
2
BlackRock
New York
$275M
3
DTC
3
Deep Track Capital
Connecticut
$27.5M
4
Pictet Asset Management
4
Pictet Asset Management
Switzerland
$49.4M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$49.8M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$103M
2
Alkeon Capital Management
2
Alkeon Capital Management
New York
$71M
3
Sands Capital Management
3
Sands Capital Management
Virginia
$181M
4
AQR Capital Management
4
AQR Capital Management
Connecticut
$11.8M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$106M
Name Holding Trade Value Shares
Change 		Shares
Change %
Northwestern Mutual Wealth Management
351
Northwestern Mutual Wealth Management
Wisconsin
– -$1.22K -22 Closed
BTI
352
Blue Trust Inc
Georgia
– -$247 -6 Closed
11 12 13 14
15